Follow
Lejla Daruka
Lejla Daruka
MTA Szegedi biológiai kutatóközpont
Verified email at brc.hu
Title
Cited by
Cited by
Year
Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides
V Lázár, A Martins, R Spohn, L Daruka, G Grézal, G Fekete, M Számel, ...
Nature microbiology 3 (6), 718-731, 2018
3552018
Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance
R Spohn, L Daruka, V Lázár, A Martins, F Vidovics, G Grézal, O Méhi, ...
Nature communications 10 (1), 4538, 2019
2832019
Exercise training and calorie restriction influence the metabolic parameters in ovariectomized female rats
A Pósa, R Szabó, K Kupai, A Csonka, Z Szalai, M Veszelka, S Török, ...
Oxidative medicine and cellular longevity 2015 (1), 787063, 2015
592015
Dual action of the PN159/KLAL/MAP peptide: Increase of drug penetration across caco-2 intestinal barrier model by modulation of tight junctions and plasma membrane permeability
A Bocsik, I Gróf, L Kiss, F Ötvös, O Zsíros, L Daruka, L Fülöp, M Vastag, ...
Pharmaceutics 11 (2), 73, 2019
452019
Cotranslational protein assembly imposes evolutionary constraints on homomeric proteins
E Natan, T Endoh, L Haim-Vilmovsky, T Flock, G Chalancon, JTS Hopper, ...
Nature structural & molecular biology 25 (3), 279-288, 2018
452018
Rapid evolution of reduced susceptibility against a balanced dual-targeting antibiotic through stepping-stone mutations
P Szili, G Draskovits, T Révész, F Bogár, D Balogh, T Martinek, L Daruka, ...
Antimicrobial agents and chemotherapy 63 (9), 10.1128/aac. 00207-19, 2019
422019
Chemical-genetic profiling reveals limited cross-resistance between antimicrobial peptides with different modes of action
B Kintses, PK Jangir, G Fekete, M Számel, O Méhi, R Spohn, L Daruka, ...
Nature Communications 10 (1), 5731, 2019
352019
Rational design of balanced dual-targeting antibiotics with limited resistance
A Nyerges, T Tomašič, M Durcik, T Revesz, P Szili, G Draskovits, F Bogar, ...
PLoS biology 18 (10), e3000819, 2020
292020
New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens
M Durcik, Á Nyerges, Ž Skok, DG Skledar, J Trontelj, N Zidar, J Ilaš, ...
European journal of medicinal chemistry 213, 113200, 2021
262021
New metabolic influencer on oxytocin release: the ghrelin
R Szabó, R Ménesi, A H. Molnár, Z Szalai, L Daruka, G Tóth, J Gardi, ...
Molecules 24 (4), 735, 2019
142019
Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides. Nat Microbiol 3: 718–731
V Lázár, A Martins, R Spohn, L Daruka, G Grézal, G Fekete, M Számel, ...
142018
Csörgo† B
R Spohn, L Daruka, V Lázár, A Martins, F Vidovics, G Grézal, O Méhi, ...
Györkei Á, Bódi Z, Faragó A, Bodai L, Földesi I, Kata D, Maróti G, Pap B …, 2019
72019
Rationally designed foldameric adjuvants enhance antibiotic efficacy via promoting membrane hyperpolarization
KN Bhaumik, A Hetényi, G Olajos, A Martins, R Spohn, L Németh, B Jojart, ...
Molecular Systems Design & Engineering 7 (1), 21-33, 2022
62022
Proteome-wide landscape of solubility limits in a bacterial cell
Á Györkei, L Daruka, D Balogh, E Őszi, Z Magyar, B Szappanos, G Fekete, ...
Scientific Reports 12 (1), 6547, 2022
42022
Chemical-genetic profiling reveals cross-resistance and collateral sensitivity between antimicrobial peptides
B Kintses, PK Jangir, G Fekete, M Számel, O Méhi, R Spohn, L Daruka, ...
bioRxiv, 542548, 2019
42019
Antibiotic usage promotes the evolution of resistance against gepotidacin, a novel multi-targeting drug
P Szili, G Draskovits, T Révész, F Bogar, D Balogh, T Martinek, L Daruka, ...
bioRxiv, 495630, 2018
32018
Antibiotics of the future are prone to resistance in gram-negative pathogens
L Daruka, MS Czikkely, P Szili, Z Farkas, D Balogh, E Maharramov, TH Vu, ...
bioRxiv, 2023.07. 23.550022, 2023
22023
New N-phenylpyrrolamide inhibitors of DNA gyrase with improved antibacterial activity
AE Cotman, F Fulgheri, M Piga, P Peršolja, DB Tiz, Ž Skok, M Durcik, ...
RSC advances 14 (39), 28423-28454, 2024
12024
Genomic surveillance as a scalable framework for precision phage therapy against antibiotic-resistant pathogens
M Koncz, T Stirling, HH Mehdi, O Méhi, B Eszenyi, A Asbóth, G Apjok, ...
Cell 187 (21), 5901-5918. e28, 2024
2024
Chemically diverse antimicrobial peptides induce hyperpolarization of the E. coli membrane
KN Bhaumik, R Spohn, A Dunai, L Daruka, G Olajos, F Zákány, A Hetényi, ...
Communications Biology 7 (1), 1264, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20